期刊文献+

Y盒结合蛋白1在SK-BR-3乳腺癌细胞增殖中的作用 被引量:1

Roles of Y box-binding protein 1 in SK-BR-3 breast cancer proliferation
原文传递
导出
摘要 目的探讨Y盒结合蛋白1(YBl)在乳腺癌细胞增殖中的作用。方法收集河北大学附属医院2013年6-8月的乳腺浸润性导管癌及癌旁正常乳腺组织标本,实时定量PCR(qRT-PCR)分析YBl基因的mRNA水平;培养乳腺上皮细胞HBL-100和乳腺癌细胞MCF-7、MDA-MB-231和SK-BR-3,qRT-PCR观察YBl的表达水平,MTS法分析细胞增殖活力;血小板源性生长因子BB(PDGF-BB)刺激SK-BR-3细胞,观察YBl的表达水平;应用特异性小干扰RNA敲低内源性YBl或应用GFP-YBl腺病毒载体过表达外源性GFP-YBl,MTS法观察敲低或过表达YBl对细胞增殖的影响。结果与癌旁正常乳腺组织相比,乳腺癌组织中YBl表达水平显著增高(P〈0.05),增殖能力较强的MDA-MB-231和SK.BR.3乳腺癌细胞株中YBl的表达水平显著高于乳腺上皮细胞HBL-100(P〈0.05)。PDGF.BB可上调SK-BR-3细胞中YBl表达水平。敲低内源性YBl可抑制SK-BR-3细胞增殖,而过表达外源性YBl可促进SK-BR-3细胞增殖活性。结论YBl在乳腺癌组织中表达升高并促进乳腺癌细胞增殖。 Objective To explore the roles of Y box-binding protein 1 (YB-1) in breast cancer cell proliferation. Methods Twenty cases of surgical removal of breast cancer tissue (diagnosed with invasive ductal carcinoma, stage Ⅱ, by postoperative paraffin pathology) and normal breast tissues adjacent to carcinoma were collected during June 2013 to August 2013. Quantitative real-time PCR (qRT-PCR) was performed to detect the YB1 mRNA levels. Cultured mammary epithelial cells (HBL-100) and breast cancer cells (MCFT, MDA-MB-231 & SK-BR-3 cells) were harvested and qRT-PCR was performed to detect the YB1 mRNA levels. SK-BR-3 cells were stimulated with various concentrations of PDGF-BB and YB1 expression levels were detected by qRT-PCR. Down-regulation or over-expression of YB1 by si-YB1 or Ad- GFP-YB1 was detected in SK-BR-3 ceils. And MTS cell proliferation assay kit was used to detect cell proliferation. Results YB1 mRNA levels were significantly higher in breast cancer tissues and MDA-MB- 231 and SK-BR-3 breast cancer cell lines than that in adjacent normal breast tissues and HBL-100 mammary epithelial cells respectively ( P 〈 0. 05 ). YB1 expression levels increased in PDGF-BB stimulated SK-BR-3 cells in a dose-dependent manner. Conclusion A down-regulation of endogenous YB1 decreases and an over-expression of exogenous YB1 promotes the proliferation activity in SK-BR-3 cells.
出处 《中华医学杂志》 CAS CSCD 北大核心 2014年第36期2804-2807,共4页 National Medical Journal of China
基金 国家自然科学基金青年基金(1301143) 河北省自然科学基金青年基金(C2013201271) 河北省卫生厅项目(20100456) 河北大学自然科学研究计划项目(2013-266) 河北大学医学学科专项基金(2013A1001、201381002)
关键词 Y盒结合蛋白质1 乳腺肿瘤 增殖 Y-box-binding protein 1 Breast neoplasms Proliferation
  • 相关文献

参考文献13

  • 1St'hmid D, I^itzniann MF. Associationbetween physical activity and mortalityamong breast cancer and colorectalcancer survivors: a syslematic reviewami meta-analysis [ J ]. Ann Oncol,2014, 25: 1293-1311.
  • 2Bartsch R, Frings S, Marty M, et al.Present and future breasl cancermanagemenl-l)encli lo bedside andhack: a positioning paper of academia,regulatory authorities ami pharmaceutical industry [ J ]. AnnOncol, 2014, 25:773-780.
  • 3边莉,刘毅,王涛,张少华,邵志敏,佟仲生,宋尔卫,王晓稼,廖宁,江泽飞.循环肿瘤细胞动态变化对转移性乳腺癌患者治疗反应及预后的预测价值[J].中华医学杂志,2014,94(4):265-268. 被引量:18
  • 4何英剑,李金锋,王天峰,解云涛,范照青,王立泽,英旻,欧阳涛.不同分子亚型浸润性乳腺癌治疗后生存情况分析[J].中华医学杂志,2013,93(46):3663-3666. 被引量:14
  • 5Shi JH , Zheng B, Chen S, et ai. Novel insight into Y-hox bindingprotein 1 the regulationg of smooth musle cell proliferation throughtargeting GC Itox-dependenl genes [ J ]. FEBS2013,587 :1326-1332.
  • 6Kohno K, Izumi H, Uchiumi T, et al. The pleiotropio functions ofthe Y-l)Ox-binding protein, YB-1 [ J] . Bioessays, 2003 , 25:691-698.
  • 7Lyabin I)N, Eliseeva IA, Ovchinnikov LP, et al. YB-1 protein:functions and regulation[ J]. Wiley Interdiscip Rev KNA , 2014,5:95-110.
  • 8Kang Y, Hu W, Ivan C, et al. Role of Focal Adhesion kinase inregulating YB-1-mediated paclitaxel resistance in ovarian cancer[J]. J Natl Cancer Inst, 2013, 105: 1485-1495.
  • 9Imada K, Shiola M , Knliashi K, et al. Mutual regulation betweenRaf/MKK/ERK signaling and Y-l)ox-hinding protein-1 promotesprostate cancer progression [ J ]. Clin Cancer Res, 2013,19:46384650.
  • 10Shibata T, Kan H, Murakami Y,et al. Y-box binding protein-1contributes 1() both HER2/ErbB2 expression and lapatinibsensitivity in human gastric cancer cells [ J] . Mol Cancer Ther,2013,12: 737-746.

二级参考文献14

  • 1Carey LA, Pemu CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. lAMA, 2006,295 : 2492 -2502.
  • 2Perou CM, Serlie T, Eisen MB, et al. Molecular portraits of human breast tumors. Nature ,2000,406:747-752.
  • 3Carey LA, Dees EC, Sawyer L, et al. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res ,2007,13:2329-334.
  • 4Yiu W], Lu IS, Di GH, et al. chnicopathological features of the triple-negative tumors in Chinese breast cancer patients. Breast Cancer Res Treat,2009,115:325-333.
  • 5Konecny G, Pauletti G, Pegram M, et al. Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer. J Natl Cancer Inst, 2003, 95 : 142-153.
  • 6Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad sci U S A,2003,100:8418-8423.
  • 7Nguyen PL Taqhian AG, Katz MS, et al. Breast Cancer Subtype Approximated by Estrogen Receptor, Progesterone Receptor, and HER-2 Is Associated With Local and Distant Recurrence After Breast-Conserving Therapy. J Clin Oneol, 2008, 26:2373-2378.
  • 8Hugh J, Hanson J, Cheang MC, et al. Breast Cancer Subtypes and Response to Doeetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial. J Clin Oncol, 2009, 27 : 1168-1176.
  • 9Harbeck N, Dettmar P, Thomssen C, et al. Prognostic impact of tumor biological factors on survival in node-negative breast cancer. Anticancer Res, 1998, 18:2187-2197.
  • 10何奇,王杰,邵玉国,周晓云,邵志敏.三阴性乳腺癌的临床病理特征与预后分析[J].中华医学杂志,2009,89(4):243-247. 被引量:15

共引文献29

同被引文献11

  • 1Maciejczyk A, Szelachowska J, Ekiert M ,et al. Elevated nuclear YB1 expression is associated with poor survival of patients with early breast cancer[J]. Anticaneer Res,2012, 32(8) : 3177-3184.
  • 2Cybulski M, Jarosz B, Nowakowski A, et al. Cyelin a correlates with YB1, progression and resistance to chemotherapy in human epithelial ovarian cancer[ J ]. Antieaneer Res,2015,35 (3) : 1715-1721.
  • 3Harada M, Kotake Y, Ohhata T,et al. YB-1 promotes transcription of cyelin D1 in human non-small-cell lung cancers [ J ]. Genes Cells, 2014,19(6) : 504-516.
  • 4Imada K, Shiota M, Kohashi K, et al. Mutual regulation between Raf/ MEK/ERK signaling and Y-box-binding protein-1 promotes prostate cancer progression [ J ]. Clin Cancer Res, 2013, 19 ( 17 ) : ,1.63R -zl.650.
  • 5Znaor A, Lortet-Tieulent J, Laversanne M, et al. International varia- tions and trends in renal cell carcinoma incidence and mortality[ J]. Eur Uro1,2015,67 ( 3 ) : 519-530.
  • 6Wang Y,Yue D,Xiao M,et al. C1QBP negatively regulates the acti- vation of oncoprotein YBX1 in the renal cell carcinoma as revealed by interactomicsanalysis [ J ]. J Proteome Res,2014,14 (2) : 804-813.
  • 7Wang Y,Chen Y,Geng H,et al. Overexpression of YB1 and EZH2 are associatedwith cancer metastasis and poor prognosis in renal cell carcinomas[ J]. Tumor Biol,2015 : 1-8.
  • 8Wilhelm SM, Carter C, Tang LY, et al. BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis[J]. Cancer Res,2004,64(19) : 7099-7109.
  • 9张涛,何平平,周俊,罗志刚,欧阳新平.YB-1基因沉默抑制前列腺癌细胞的增殖和迁移[J].重庆医学,2013,42(30):3641-3643. 被引量:1
  • 10苑博,张晓芳,陈雅婧,田芳,闫雪苗,刘运德,岳丹.HABP1基因慢病毒干扰和表达载体的构建及表达[J].临床检验杂志,2013,31(10):782-785. 被引量:2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部